Profilo
Diego Cadavid worked as a Senior Medical Director at Biogen, Inc. from 2008 to 2016.
Prior to that, he was an Associate Professor at New Jersey Medical School from 1999 to 2008.
He also worked as a Senior Vice President-Clinical Development at Fulcrum Therapeutics, Inc. In 2020, he became the Chief Medical Officer at X4 Pharmaceuticals, Inc. Dr. Cadavid holds a doctorate degree from Pontifical Xavierian University.
Precedenti posizioni note di Diego Cadavid
| Società | Posizione | Fine |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 29/11/2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2016 |
New Jersey Medical School
New Jersey Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
| FULCRUM THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Diego Cadavid
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
New Jersey Medical School
New Jersey Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Pontifical Xavierian University
Pontifical Xavierian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















